Search

ImmunityBio Inc

Avatud

SektorTervishoid

7.77 -0.26

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.46

Max

7.95

Põhinäitajad

By Trading Economics

Sissetulek

-571M

-633M

Müük

5.9M

44M

Aktsiakasum

-0.08

Kasumimarginaal

-1,431.439

Töötajad

684

EBITDA

-569M

-600M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+66.67% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

4. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-220M

7.6B

Eelmine avamishind

8.03

Eelmine sulgemishind

7.77

Uudiste sentiment

By Acuity

50%

50%

146 / 342 Pingereas Healthcare

ImmunityBio Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. juuni 2026, 23:56 UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

24. juuni 2026, 23:52 UTC

News
Correlated Moves
Social Media

Applied Materials shares rose in after-market trading, boosted by strong earnings from Micron Technology and positive sentiment in the semiconductor sector.

24. juuni 2026, 23:52 UTC

News
Correlated Moves

Lam Research Corp shares rise in after-market trading, driven by positive sentiment from Micron Technology's strong results and broader semiconductor sector gains.

24. juuni 2026, 23:41 UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, following a session marked by declines and mixed global market dynamics.

24. juuni 2026, 23:41 UTC

News
Correlated Moves

Alphabet Inc. shares are lower in after-market hours, down $1.13 to about $345.00, amid a broader decline in the Interactive Media & Services sector.

24. juuni 2026, 23:41 UTC

Event
News

Trip.com Group Ltd's stock is lower in after-market trading following a first-quarter net income decline and reduced second-quarter revenue guidance.

24. juuni 2026, 23:41 UTC

ETF Constituents
News
Social Media

Invesco QQQ Trust Series I rises in after-market trading, boosted by strong Q3 earnings from Micron Technologies and positive sentiment from tech sector recovery.

24. juuni 2026, 23:41 UTC

News
Correlated Moves

Western Digital shares rose sharply in after-hours trading following strong Q3 results from Micron Technology, which beat earnings and revenue expectations.

24. juuni 2026, 23:41 UTC

Correlated Moves
News

iShares Silver Trust is trading higher in after-market hours, reflecting recovery after recent declines despite slight decreases in gold prices.

24. juuni 2026, 23:41 UTC

Correlated Moves
News

SPDR Gold Shares advance in after-market trading despite lower gold prices and a slight decline in silver. U.S. stocks show generally higher performance.

24. juuni 2026, 23:41 UTC

Correlated Moves
News
Social Media

Qualcomm shares rose after Investor Day, doubling fiscal 2029 non-handset revenue targets to $40 billion and announcing a partnership with Meta Platforms for data center CPUs.

24. juuni 2026, 23:41 UTC

News

Comcast shares are higher after reports of its subsidiary Sky acquiring ITV's Broadcast unit for about £1.6 billion, pending legal review.

24. juuni 2026, 23:36 UTC

News

Gilead Sciences' Trodelvy receives FDA approval for first-line treatment of triple-negative breast cancer, boosting shares in after-market hours.

24. juuni 2026, 23:32 UTC

News
Event
Social Media

Micron Technology reported record third-quarter revenue of $41.46 billion and strong fourth-quarter guidance, driving shares higher in after-market trading.

24. juuni 2026, 23:31 UTC

News
Social Media

United States Oil Fund LP is trading higher in after-market hours following a larger-than-expected drop in U.S. crude oil inventories for the week.

24. juuni 2026, 23:11 UTC

Correlated Moves
News
Social Media

Meta shares rise in after-market trading following a strategic partnership with Qualcomm and government discussions on AI oversight.

24. juuni 2026, 23:06 UTC

News
Social Media

Tesla Inc shares are higher in after-market trading, supported by a multi-year agreement with NatPower for battery energy storage systems in Europe.

24. juuni 2026, 23:06 UTC

Correlated Moves
News

The iShares 7-10 Year Treasury Bond ETF is trading higher in after-market hours, reflecting routine movement near its one-month trading range.

24. juuni 2026, 23:06 UTC

News
Correlated Moves
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust rises in after-market trading, aided by strong earnings from Micron Technologies and lower oil prices this week.

24. juuni 2026, 23:05 UTC

News
Correlated Moves

The Vanguard Total Bond Market ETF is higher in after-market hours, reflecting broader market recovery amid easing concerns over U.S.-Iran negotiations affecting energy supply.

24. juuni 2026, 23:02 UTC

News
ETF Constituents

The Vanguard Growth ETF is gaining in after-market trading, supported by strong performances from AMD and KLA Corporation. Oil prices have declined below $80 per barrel.

24. juuni 2026, 23:02 UTC

News
Correlated Moves

The iShares 20+ Year Treasury Bond ETF is higher in after-market trading, buoyed by U.S. Bancorp's dividend increase and positive sentiment in fixed-income securities.

24. juuni 2026, 23:02 UTC

News
ETF Constituents
Macro News

Vanguard Information Technology ETF gains after-hours, supported by Micron Technology's record earnings and strong performance from top holdings.

24. juuni 2026, 23:01 UTC

News

Charter Communications Inc. gains in after-market trading, supported by positive sentiment from the Federal Reserve's stress test results and strong mobile segment growth.

24. juuni 2026, 22:51 UTC

News

Booking Holdings Inc may benefit from falling oil prices, with WTI crude below $70 and Brent at $74, potentially boosting travel demand. Shares are roughly flat in after-market trading.

24. juuni 2026, 20:07 UTC

News

Business confidence in Germany rose, lifting the EUR/ZAR higher during Wednesday's session. The Ifo index increased to 85.6 points, surpassing expectations.

24. juuni 2026, 20:06 UTC

News
Correlated Moves

The US Dollar Index has risen, supporting higher trading in USD/DKK amid a broader trend of strength in the U.S. dollar.

24. juuni 2026, 20:06 UTC

Macro Event
News
Correlated Moves

The U.S. current account deficit widened to $226.8 billion, influencing notable volatility in the USD/CZK exchange rate, which is higher since Tuesday's close.

24. juuni 2026, 20:06 UTC

News
Correlated Moves

The US dollar's strength drives USD/SGD higher, reflecting a flight to safety amid economic and geopolitical concerns. The pair remains near its one-month trading range.

24. juuni 2026, 20:06 UTC

News
Correlated Moves

USD/SEK is trading higher as the US Dollar Index strengthens amid a flight to safety, recovering from a midday dip while above its 20-day moving average.

Võrdlus sarnastega

Hinnamuutus

ImmunityBio Inc Prognoos

Hinnasiht

By TipRanks

66.67% tõus

12 kuu keskmine prognoos

Keskmine 13 USD  66.67%

Kõrge 15 USD

Madal 12 USD

Põhineb 3 Wall Streeti analüütiku instrumendi ImmunityBio Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

3

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

146 / 342 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest ImmunityBio Inc

ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Its platforms for the development of biologic product candidates include antibody-cytokine fusion proteins; DNA, RNA, and recombinant protein vaccines; and cell therapies. The company's platforms have generated therapeutic agents that are currently being or planned to be studied in clinical trials across various indications in liquid and solid tumors, including bladder, lung and colorectal cancers, and glioblastoma multiforme. Its lead biologic product candidate is Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute. It also has license agreements with 3M Innovative Properties Company; Access to Advanced Health Institute; LadRx Corporation; Sanford Health; Shenzhen Beike Biotechnology Co. Ltd.; Viracta Therapeutics, Inc.; and GlobeImmune, Inc. The company is based in San Diego, California.
help-icon Live chat